Skip to main content
Log in

The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice

  • Ulcerogenicity
  • Published:
Agents and Actions Aims and scope Submit manuscript

Conclusions

The findings presented in this report show that: (1) 5-lipoxygenase inhibitors and some leukotriene antagonists protect the gastric mucosa against lesions induced by oral or parenteral administration of most NSAIDs, with the possibility of some variation in effects with aspirin.

(2) These observations suggest that overproduction of leukotrienes and other products of 5-lipoxygenase activity may play a role in the development of acute gastric mucosal damage induced by NSAIDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. B. J. R. Whittle,Arachidonic acid metabolites and the gastrointestinal toxicity of antiinflammatory agents. Prostaglandins21, (Suppl.), 113–118 (1981).

    Article  Google Scholar 

  2. K. D. Rainsford,Mechanisms of gastric contrasted with intestinal damage by nonsteroidal antiinflammatory drugs. In:Side Effects of Antiinflammatory Drugs. Vol. II (Eds.: K. D. Rainsford and G. P. Velo) pp. 3–26. MIP Press, Lancaster 1987.

    Google Scholar 

  3. J. R. Walker and J. Harvey,Actions of antiinflammatory drugs on leukotriene and prostaglandin metabolism: relationships to asthma and other hypersensitivity reactions. Inside effects of antiinflammatory/analgesic drugs. (Eds. K. D. Rainsford and G. P. Velo) pp. 227–238 Raven Press, New York 1984.

    Google Scholar 

  4. R. G. Pendleton and J. R. Stavorski,Evidence for differing leukotriene receptors in gastric musosa. Europ. J. Pharmacol.125, 297–299 (1986).

    Article  Google Scholar 

  5. P. Salvati and B. J. R. Whittle,Investigation of the vascular actions of arachodonate lipoxygenase and cyclooxygenase products of the perfused stomach of rat and rabbit. Prostaglandin22, 141–156 (1981).

    Article  Google Scholar 

  6. K. D. Rainsford,An economical and highly sensitive assay for the gastrotoxicity of antiinflammatory drugs and anti-ulcer agents, in cholinomimetically-sensitized mice. Dig. Dis. Sci.30, A32 (1985).

    Article  Google Scholar 

  7. D. F. Magee, S. Naruse and A. Pap,Comparison of the actions of cholinomimetics and pentagastrin on gastric secretion in dogs. Br. J. Pharmacol.84, 347–355 (1985).

    PubMed  Google Scholar 

  8. S. M. Coutts, A. Khandwala, R. Van Inwegen, U. Chakraborty, J. Musser, J. Bruens, N. Jariwala, V. Dally-Meade, R. Ingram, T. Puss, H. Jones, E. Neiss and I. Weinryb,Arylmethyl phenyl ethers. A new class of specific inhibitors of 5-lipoxygenase. InProstaglandins, leukotrienes, and lipoxins. (Ed. J. M. Bailey) pp. 627–637 Plenum Press, New York 1985.

    Google Scholar 

  9. Y. Guindon, Y. Girard, A. Maycock, A. W. Ford-Hutchinson, J. G. Atkinson, P. C. Belanger, A. Dallob, D. DeSousa, H. Dougherty, R. Egan, M. M. Goldenberg, E. Ham, R. Fortin, P. Hamel, R. Hamel, C. K. Lau, Y. Leblanc, C. S. McFarlane, H. Piechuta, M. Thérien, C. Yoakim and J. Rokach, L-651,392 a novel, potent and selective 5-lipoxygenase inhibitor. InAdvances in prostaglandins, thromboxane and leukotriene research. (Eds. B. Samuelsson et al.) pp. 554–557. Raven Press, New York 1987.

    Google Scholar 

  10. K. H. Leung,Selective inhibition of leukotriene C 4 synthesis in human neutrophils by ethacrynic acid. Biochem. Biophys. Res. Commun.137, 195–200 (1986).

    Article  PubMed  Google Scholar 

  11. J. Augstein, J. B. Farmer, T. B. Lee, P. Sheard and M. L. Tattersall,Selective inhibitor of slow reacting substance of anaphylaxis. Nature New Biol.245, 215–217 (1973).

    PubMed  Google Scholar 

  12. T. R. Jones, R. Young, E. Champion, L. Charette, D. Denis, A. W. Ford-Hutchinson, R. Frenette, J.-Y. Gauthier, Y. Guindon, M. Kakushima, P. Masson, A. Maycock, C. McFarlane, H. Piechuta, J. Rokach and R. Zamboni,L-649,923, sodium (βS *,γR *)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl-thio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene acceptor antagonist. Can. J. Physiol. Pharmacol.64, 1068–1075 (1986).

    PubMed  Google Scholar 

  13. J. H. Musser, D. M. Kubrak, J. Chang and A. J. Lewis,Synthesis of ((Naphthalenylmethoxy)- and ((quinolinylmethoxy)phenyl)amino)oxoalkanoic acid esters, A novel series of leukotriene D 4 antagonists and 5-lipoxygenase inhibitors. J. Med. Chem.29, 1429–1435 (1986).

    Article  PubMed  Google Scholar 

  14. J. H. Fleisch, L. E. Rinkema, K. D. Haisch, D. Swanson-Bean, T. Goodson, P. P. K. Ho and W. S. Marshall,LY-171883, 1-(2-hydroxy-3-propyl-4-(4-(1H-tetrazol-5-yl) butoxyphenyl) ethanone, an orally active leukotriene D 4 antagonist. J. Pharmacol. Exp. Ther.233, 148–157 (1985).

    PubMed  Google Scholar 

  15. G. Feuerstein,Autonomic pharmacology of leukotrienes. J. Auton. Pharmacol.5, 149–168 (1985).

    PubMed  Google Scholar 

  16. J. Chang, personal communication.

  17. K. D. Rainsford,Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment. J. Pharm. Pharmacol., in press (1987).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rainsford, K.D. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice. Agents and Actions 21, 316–319 (1987). https://doi.org/10.1007/BF01966502

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01966502

Keywords

Navigation